SCHEMBL14028149

SCHEMBL14028149

CC1CCC(Cc2ccccn2)(N(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
HRH3 Q9Y5N1 3/20 0.40
OGA O60502 1/20 0.38
HSD11B1 P28845 1/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LIN28A Q9H9Z2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
LTA4H P09960 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503756 0.84 HSD11B1 (0.36) ALDH1A1HRH3HSD11B1MAPTSMN1; SMN2
SCHEMBL20069006 0.80 CYP2D6 (0.43) ALDH1A1TSHRHRH3MAPTSMN1; SMN2
SCHEMBL20070181 0.80 RET (0.41) HRH3CHRM2CHRM4CHRM5CHRM1
SCHEMBL14409780 0.78 ALDH1A1 (0.41) ALDH1A1TSHRHRH3OGASMN1; SMN2
SCHEMBL14028057 0.76 OPRM1 (0.58) TSHROPRM1OPRK1MAOAMAOB
SCHEMBL20147391 0.75 CYP2D6 (0.42) ALDH1A1HRH3MAPTSMN1; SMN2LIN28A
SCHEMBL22857061 0.73 RET (0.38) ALDH1A1HRH3OPRM1
SCHEMBL13504027 0.73 OPRM1 (0.41) TSHRHRH3TDP1OPRM1OPRK1
SCHEMBL13503860 0.72 ACHE (0.47) TSHRTDP1OPRM1OPRK1
SCHEMBL13681416 0.72 KDM4E (0.47) ALDH1A1HRH3OGAOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD ALDH1A1 1945/4885TSHR 3557/4885HRH3 4437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.